Lexicon Pharmaceuticals (LXRX)

Lexicon Pharmaceuticals (LXRX) Financial Statements


Lexicon Pharmaceuticals Financial Overview

Lexicon Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.791; its P/E ratio is -2.60; Lexicon Pharmaceuticals is scheduled to report earnings on May 2, 2024, and the estimated EPS forecast is $-0.20. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue$ 317.00K--$ 39.00K$ 35.00K
Gross Profit$ 30.29M----
EBIT$ 17.07M$ -7.26M-$ -22.52M$ -23.88M
EBITDA$ 17.49M$ -6.89M-$ -22.41M$ -23.78M
Net Income Common Stockholders$ -44.90M$ -9.09M-$ -23.39M$ -24.59M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 256.74M$ 105.94M$ 138.36M$ 136.20M$ 61.97M
Total Assets$ 316.90M$ 162.72M$ 194.30M$ 191.69M$ 112.33M
Total Debt$ 98.77M$ 48.84M$ 0.00$ 30.63M$ 25.42M
Net Debt$ -157.97M$ -57.09M$ -138.36M$ -105.58M$ -36.55M
Total Liabilities$ 130.36M$ 74.67M$ 450.72M$ 47.67M$ 41.49M
Stockholders Equity$ 186.36M$ 88.05M$ 422.12M$ 144.02M$ 70.83M
Cash Flow-
Free Cash Flow$ -38.26M$ -31.86M-$ -19.44M$ -24.42M
Operating Cash Flow$ -38.12M$ -31.61M-$ -19.44M$ -24.42M
Investing Cash Flow$ -74.61M$ 12.09M-$ -77.20M$ -13.65M
Financing Cash Flow$ 188.96M$ -824.00K-$ 94.02M$ 0.00
Currency in USD

Lexicon Pharmaceuticals Earnings and Revenue History

Lexicon Pharmaceuticals Debt to Assets

Lexicon Pharmaceuticals Cash Flow

Lexicon Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis